Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
Clinical trial NCT02234089 · COMPLETED
Trial details
- NCT number
- NCT02234089
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-09-01
- Primary completion
- 2019-06-30
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.